Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Alto Neuroscience, Inc. (NYSE: ANRO) between Feb. and Oct. 2024 should contact the Shareholders Foundation

SAN DIEGO, Aug. 18, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit for certain investors in shares of Alto Neuroscience, Inc. (NYSE: ANRO).

Investors who purchased in excess of $100,000 in shares of Alto Neuroscience, Inc. (NYSE: ANRO) between February 2, 2024 and October 22, 2024, have certain options and there are short and strict deadlines running. Deadline: September19, 2025. NYSE: ANRO investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On July 21, 2025, a NYSE: ANRO investor filed a lawsuit over alleged securities laws violations by Alto Neuroscience, Inc. The plaintiff alleges that the Offering Documents that were filed in connection with the Company's IPO conducted on or about February 2, 2024 and that certain statements made by the defendants between February 2, 2024 and October 22, 2024 were false and/or misleading statements and/or failed to disclose that ALTO-100 was less effective in treating MDD than Defendants had led investors to believe, that accordingly, ALTO-100's clinical, regulatory, and commercial prospects were overstated, that as a result, Alto's business and/or financial prospects were overstated, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased Alto Neuroscience, Inc. (NYSE: ANRO) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
mail@shareholdersfoundation.com 
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lawsuit-deadline-investors-who-purchased-over-100-000-worth-of-shares-of-alto-neuroscience-inc-nyse-anro-between-feb-and-oct-2024-should-contact-the-shareholders-foundation-302531872.html

SOURCE Shareholders Foundation, Inc.